Skip to content
Recall Observatory FDA recall evidence

Drug product

Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited, Pithampur (M.P)- 454 775 INDIA, NDC# 68180-967-03

D-0167-2025

December 20, 2024

Class II

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 95892
Status
Terminated
Classification
Class II
Quantity
480 1000-count bottles
Official record key
drug-enforcement:D-0167-2025

Official wording

Reason: Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.

Code information: Lot# LA01276, Exp Date: 07/2026

Distribution pattern: One US distributor in Ohio.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications